| Drug Name |
Nebivolol |
| Drug ID |
BADD_D01541 |
| Description |
Nebivolol is a racemic mixture of 2 enantiomers where one is a beta adrenergic antagonist and the other acts as a cardiac stimulant without beta adrenergic activity.[A182579] Treatment with nebivolol leads to a greater decrease in systolic and diastolic blood pressure than [atenolol], [propranolol], or [pindolol].[A182579] Nebivolol and other beta blockers are generally not first line therapies as many patients are first treated with thiazide diuretics.[A182594]
Nebivolol was granted FDA approval on 17 December 2007.[L7985] |
| Indications and Usage |
Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988] |
| Marketing Status |
approved; investigational |
| ATC Code |
C07AB12 |
| DrugBank ID |
DB04861
|
| KEGG ID |
D05127
|
| MeSH ID |
D000068577
|
| PubChem ID |
71301
|
| TTD Drug ID |
D0Z1UA
|
| NDC Product Code |
13668-356; 31722-586; 51407-486; 62559-276; 13668-354; 51407-483; 59651-137; 62559-278; 0904-7226; 62559-275; 63629-9589; 70756-025; 71209-058; 72241-033; 72241-034; 72241-035; 62559-277; 0904-7189; 70756-291; 71209-059; 13668-355; 31722-587; 43547-527; 50090-5708; 50090-5761; 50090-5775; 59651-140; 63629-9423; 63629-9424; 70756-292; 27241-182; 51407-485; 59651-139; 67877-391; 67877-392; 67877-393; 70518-3527; 71209-060; 72241-032; 65977-0048; 60687-641; 60687-652; 67877-390; 70756-293; 0904-7190; 0904-7225; 27241-179; 27241-180; 31722-585; 43547-524; 43547-525; 51407-484; 71209-061; 13668-353; 27241-181; 31722-588; 50090-5752; 59651-138 |
| UNII |
030Y90569U
|
| Synonyms |
Nebivolol | Alpha,Alpha'-(Iminobis(Methylene))bis(6-Fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol | Bystolic | Nebilet | Silostar | Nebivolol Hydrochloride | Hydrochloride, Nebivolol | R 67555 | 67555, R | R-67555 | R67555 | Lobivon |
